A B S T R A C T Pemphigus is an antibody-mediated autoimmune skin disease in which loss of cell-to-cell contacts in the epidermis results in blister formation. Patients with pemphigus develop antibodies that bind to the keratinocyte cell surface, the site of primary pathology. The purpose of this study was to characterize the antigen(s) to which pemphigus antibodies bind. Because we could detect pemphigus antigen by indirect immunofluorescence on the surface of multiply-passaged cells in cultures of both a spontaneously transformed mouse keratinocyte cell line (Pam) and normal human epidermal cells, we used these cells as a source of antigen. In order to demonstrate biosynthesis of antigen and to characterize the antigen(s), we radiolabeled cell cultures with ['4C]glucosamine or D-[2-3H]mannose and used different pemphigus sera to immunoprecipitate antigen from nonionic detergent extracts of these labeled cells. Specifically precipitated radiolabeled molecules were identified using sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) and fluorography. Sera from five of seven pemphigus patients specifically precipitated (from extracts of both Pam cells and human epidermal cells) a molecule that, when reduced, was -130 kD, whereas seven normal human sera and two pemphigoid sera did not precipitate this molecule. The findings that (a) these precipitated molecules comigrated on SDS-PAGE and that (b) the 130-kD molecule could no longer be precipitated from cell extracts that had been previously reacted with a pemphigus serum, indicate that reactive pemphigus sera bind the same molecule. The molecule was not detected in the culture medium of these cells. This finding, along with the cell surface
INTRODUCTION
Pemphigus is an antibody-mediated autoimmune blistering skin disease that is almost always fatal if untreated. The histology of pemphigus blisters demonstrates intraepidermal vesicles that result from acantholysis, a loss of cell-to-cell contacts and rounding up of epidermal cells (1) . Direct immunofluorescence of lesional or perilesional skin in pemphigus demonstrates antibody (usually IgG) bound, in vivo, to the epidermis and forming an intercellular staining pattern (2) . Indirect immunofluorescence has been used to show that most patients with pemphigus also have circulating antibodies that bind to normal epidermis of most mammals and birds in the same intercellular pattern (2, 3) . Although light microscopic tissue immunofluorescence patterns appear to be intercellular, immunofluorescence performed on cell suspensions and immunoelectron microscopy have demonstrated that pemphigus antibodies bind to the keratinocyte cell surface (4) (5) (6) (7) (8) (9) . The binding of pemphigus IgG to the keratinocyte cell surface probably results in the release of proteolytic enzymes that can cause acantholysis (6, (10) (11) (12) . Thus, the interaction of pemphigus antibody with a cell surface antigen or antigens is probably a mediator of disease. Furthermore, most authors (13) (14) (15) (16) , but not all (17) , have (18) , was used at passages 10-12. Normal human epidermal cells (HEC)' derived from neonatal foreskins were cultured on collagen substrates as previously reported (19) , and used at passage 3. Fibroblasts were derived from the dermis of BALB/c mice (20) and used in the first passage, or from the dermis of human foreskins (19) , and used at passage 11. 
Radiolabeling

RESULTS
Immunofluorescence of pemphigus antigen in cultured cells. Previously we have shown that pemphigus antigen can be detected by indirect immunofluorescence on the cell surface of the large plate-like cells located superficially in cell colonies of methanol and acetone fixed cultures of HEC (22) and Pam cells (18) . Using an indirect immunofluorescence procedure on unfixed, living Pam cells we found a greater sensitivity and could detect pemphigus antigen on the cell surfaces of most cells, both the large superficial cells and the smaller cells lower in the colonies and on the substrate (Fig. 1) . The fact that pemphigus antigen could be detected in these cultures of multiply-passaged cells suggested that they were appropriate to use for biosynthetic labeling, isolation, and characterization of the antigen.
Immunoprecipitation and characterization of pemphigus antigen. Preliminary studies using var- Sera from five of seven pemphigus patients specifically precipitated, from extracts of both Pam cells and HEC, a molecule that when reduced on SDS-PAGE had an apparent molecular mass of 130 kD (Fig. 2) . The specificity of this reaction is shown by the finding that seven normal human sera and two pemphigoid sera did not precipitate this molecule (Fig. 2) . In order to demonstrate that different pemphigus sera that precipitate this antigen actually precipitate the same molecule, we precipitated the antigen from an extract of Pam cells with one pemphigus serum, then used another to try to immunoprecipitate the antigen from the supernatant. The results of two experiments showed that one pemphigus serum depleted or markedly reduced the antigen with which a second pemphigus serum could react (Fig. 3) . In contrast, normal human sera did not deplete the antigen from extracts of these cells. Thus it is likely that the molecules that are pre- (Fig. 4) or human fibroblasts, indicating that it is not synthesized by fibroblasts in culture. Additional studies were done to further characterize this 130-kD molecule. The molecule, when electrophoresed unreduced on SDS-PAGE, could not be detected, presumably because it did not penetrate the gel. This finding suggests that, when unreduced, the molecule may exist as high molecular weight aggregates. In order to demonstrate that the molecule contained protein, we incubated the immunoprecipitates with either S. aureus V8 protease or chymotrypsin before electrophoresing them. The specifically precipitated 130-kD molecule was degraded by both proteases (Fig. 5) indicating that it contains protein. The presence of protein in this molecule was also demonstrated by the finding that it could be biosynthetically labeled with a mixture of 14C-amino acids (Fig. 6) then, suggests that it is a glycoprotein. This was confirmed by biosynthetically labeling the molecule with D-[2-3H]mannose (Fig. 7) .
Taken together these data indicate that some, but (28) . Affinity chromatography, with a serum from a patient with pemphigus vulgaris, was used to detect a protein of molecular weight 18 kD from an extract of guinea pig epidermis, but this protein also contained RNA and was said to be impure (29) . A group of proteins in the 68-kD range partially purified from extracts of human esophagus was able to decrease the immunofluorescence titer of two pemphigus vulgaris sera (30) . For several reasons it is difficult to compare the antigens described in these studies to the 130-kD glycoprotein that we have characterized. First, in these prior studies the source of the antigen varied but did not include human or mouse keratinocytes that we used. Second, two of these studies (29, 30) deal with rather impure and heterogeneous substances and did not use protease inhibitors in extraction procedures. Finally, these prior studies rely on immunofluorescence blocking assays using only one or two sera. In the present study, rather than relying on immunofluorescence blocking, which is an indirect method of detecting antigen, we directly characterized the an-tigen that bound the IgG of several different pemphigus sera.
The present study clearly demonstrates that not all pemphigus sera bind the same molecule. This finding is not simply due to differences in antibody titer among different pemphigus sera because the indirect immunofluorescence titers of the two sera that did not precipitate the 130-kD molecule were 160 and 320, whereas the titers of those sera that did precipitate the molecule were equivalent, 80-320. Whether this difference in specificity can be related to the clinical type of pemphigus (e.g., foliaceus, in which the blister occurs in the superficial epidermis vs. vulgaris, in which the blister is found deeper, just above the basal layer) cannot be determined from this study because most of the sera used were obtained from immunofluorescence laboratory serum banks. Thus, although the diagnosis of pemphigus was confirmed by indirect immunofluorescence, the clinical type of pemphigus could not be accurately determined without histopathology, which was unavailable in most cases. Immunofluorescence blocking studies have suggested that antibodies from patients with Brazilian pemphigus foliaceus may have different specificities than antibodies of patients with pemphigus vulgaris (31) , however inability of one serum to block the binding of another serum does not prove that these sera bind to different molecules. The presence of several cell surface pemphigus antigens has also been suggested by the observation that different pemphigus sera tested on the same skin specimen may result in different immunofluorescence patterns (32, 33) . For example, some patients with pemphigus foliaceus have antibodies that only bind the superficial layers of normal epidermis (32) . However, most patients with pemphigus foliaceus have antibodies that bind all layers of normal epidermis and it has been suggested that a cell surface antigen, normally present throughout the epidermis, is missing in the lower part of the epidermis in pemphigus foliaceus lesions (33) . Thus, the superficial or deep location of the blister in pemphigus foliaceus and pemphigus vulgaris, respectively, may be due either to distinct antigenic specificity of antibodies or to a different distribution, in the epidermis, of a single reactive antigen. The present study demonstrates that some pemphigus sera do not react with the specific molecule to which many sera do bind. Further studies are necessary to determine if antibody specificity in pemphigus patients is related to the clinical type of disease.
It is clear, however, from this study that many pemphigus sera react with a specific keratinocyte cell surface glycoprotein. It is likely that the interaction of pemphigus antibody with this glycoprotein is important in triggering acantholysis, the pathologic process in pemphigus. The understanding of this interaction should yield important insights into the molecular basis of pemphigus.
